B. Metzler seel. Sohn & Co. Holding AG Makes New $716,000 Investment in Teleflex Incorporated (NYSE:TFX)

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,895 shares of the medical technology company's stock, valued at approximately $716,000.

Several other large investors also recently bought and sold shares of the business. Janus Henderson Group PLC raised its holdings in shares of Teleflex by 12.0% during the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company's stock valued at $1,223,424,000 after purchasing an additional 581,312 shares during the last quarter. Point72 Asset Management L.P. raised its stake in Teleflex by 564.3% during the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company's stock valued at $65,304,000 after buying an additional 263,743 shares during the last quarter. Cooke & Bieler LP boosted its holdings in shares of Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock worth $191,989,000 after buying an additional 172,335 shares during the last quarter. Ceredex Value Advisors LLC bought a new stake in Teleflex during the second quarter valued at about $25,550,000. Finally, National Bank of Canada FI increased its holdings in Teleflex by 1,008.2% in the 2nd quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company's stock worth $24,388,000 after acquiring an additional 104,935 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Up 0.6 %

Shares of NYSE TFX traded up $1.07 during trading on Friday, hitting $191.71. 309,439 shares of the company traded hands, compared to its average volume of 552,117. The company has a 50-day moving average price of $224.99 and a 200-day moving average price of $222.88. The firm has a market capitalization of $8.90 billion, a P/E ratio of 38.11, a P/E/G ratio of 1.95 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $185.66 and a 1 year high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company's revenue was up 2.4% on a year-over-year basis. During the same period last year, the business posted $3.64 EPS. On average, equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.71%. Teleflex's payout ratio is 27.04%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on TFX shares. Royal Bank of Canada reduced their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Stephens boosted their target price on Teleflex from $275.00 to $290.00 and gave the company an "overweight" rating in a research report on Friday, August 2nd. Truist Financial reiterated a "hold" rating and set a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research note on Friday, November 1st. Finally, Mizuho cut their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $259.25.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.